Quantcast

Latest University of Massachusetts Medical School Stories

2009-10-15 07:00:00

IRVINE, Calif., Oct. 15 /PRNewswire/ -- Accenx(TM), a leading provider of health information exchange and interoperability solutions, announced today that UMass Memorial Health Care, clinical partner of University of Massachusetts Medical School and the largest healthcare system in Central and Western Massachusetts, has selected the Accenx Exchange(TM) interoperability platform to rapidly establish a health information exchange with its community physicians. UMass Memorial was...

2009-10-13 08:00:00

CHICAGO and WORCESTER, Mass., Oct. 13 /PRNewswire-FirstCall/ -- Allscripts (Nasdaq: MDRX) announced today that UMass Memorial Health Care has selected the Allscripts Electronic Health Record (EHR) and Practice Management solution as the preferred solution for private physicians in its community, including the nearly 2,000 physicians affiliated with the health system. UMass Memorial and Allscripts will offer the solution, with onsite training and customization included, as a key...

2009-10-05 11:00:31

The University of Massachusetts Medical School says it's taking part in testing a human monoclonal antibody developed to neutralize the rabies virus. The clinical trial being conducted in Mumbai, India, is sponsored by the Serum Institute of India, which is working with the university's Massachusetts Biologic Laboratories that is manufacturing the new antibody. India is an appropriate location to do this study because of the serious problem of rabies that exists in the country, said Dr. Donna...

2009-10-01 09:45:57

Clinical trial launched in India to improve treatment for people bitten by rabid animals MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus. The clinical trial is being conducted at the King Edward Memorial Hospital in Mumbai, India, and is sponsored by the Serum Institute of India, which is working in a...

f0e93f2cafdb3031fd94ae9c05e59c8c1
2009-09-25 06:25:00

After years of theorizing about how Monarch butterflies find their way to Mexico for the winter, scientists have finally discovered that their antennas help them navigate the journey. Researchers confirmed the finding when they painted their antennas black and observed them losing their way. Butterflies have only the sun in the sky as a point of reference for direction, and since the sun is always moving, they have to constantly adjust in order to stay on the right path throughout the day....

2009-09-21 11:52:00

WOODS HOLE, Mass., Sept. 21 /PRNewswire/ -- Senate President Therese Murray, the Massachusetts Life Sciences Center, the Howard Hughes Medical Institute (HHMI), and key state officials gathered at the Marine Biological Laboratory (MBL) today to break ground on a $25 million renovation of the MBL's central research training facility, the Loeb Laboratory. This renovation will create 250 regional construction jobs over the next 15 months and will greatly enhance the MBL's and the state's...

2009-08-06 11:17:56

 Building upon a series of successful preclinical studies, researchers at MassBiologics of the University of Massachusetts Medical School (UMMS) today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody they developed that can neutralize the Hepatitis C virus (HCV).The first volunteer received the antibody known as MBL-HCV1 on July 28, 2009, and the study is now proceeding and will eventually involve 30 healthy subjects in a...

2009-05-19 06:30:00

First Patent to be Issued from Among Intradigm's Large Collection of Pending siRNA Sequence Patents PALO ALTO, Calif., May 19 /PRNewswire/ -- Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, today announced the issuance of United States patent 7,534,878, titled "Composition and Methods of RNAi Therapeutics for Treatment of Cancer and Other Neovascularization Diseases." The issued patent covers a specific double-stranded siRNA sequence...

2009-05-06 09:15:00

Taking aim at a leading cause of liver failure in the United States, a team of scientists at the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) has developed a human monoclonal antibody that neutralizes the Hepatitis C virus (HCV). The new antibody effectively neutralized the virus in culture, and then prevented infection by the virus in a pre-clinical animal model of the disease.Details of the research were presented April 23 in Copenhagen,...

2009-05-06 09:17:28

Universite de Montreal study highlights importance of socializing over food Taking aim at a leading cause of liver failure in the United States, a team of scientists at the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) has developed a human monoclonal antibody that neutralizes the Hepatitis C virus (HCV). The new antibody effectively neutralized the virus in culture, and then prevented infection by the virus in a pre-clinical animal model...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'